Phase 3 Trial Confirms Nemolizumab's Efficacy for Moderate to Severe Prurigo Nodularis Written By Medha Baranwal12 Dec 2024 8:30 PM ISTGermany: The OLYMPIA 1 Phase 3 randomized clinical trial has revealed promising outcomes for nemolizumab, a monoclonal antibody targeting...
Flap Reconstruction Yields Lowest Recurrence in Hidradenitis Suppurativa: Study Written By Dr Riya Dave12 Dec 2024 6:45 AM ISTResearchers demonstrated that flap reconstruction after wide excision is indeed the lowest recurrence rate amongst various wound closure methods for...
Elevated D-Dimer and Non-Glucocorticoid Therapies Risk Factors for Thromboembolic Events in Dermatomyositis: Study Written By Dr.Niharika Harsha B10 Dec 2024 8:00 PM ISTA recent study found that the prevalence of thromboembolic events is increased in individuals with Dermatomyositis with elevated D-dimer levels and...
JAMA Study Finds Deucravacitinib Effective and Safe for Psoriasis Patients Written By Jacinthlyn Sylvia9 Dec 2024 8:00 PM ISTThis recent 3-year study revealed that deucravacitinib which is an oral treatment for moderate to severe plaque psoriasis to offer a sustainable and...
A Comparative Analysis: Selenium Sulfide vs Ketoconazole in Seborrheic Dermatitis and Dandruff Dr. Kamal Kant Kohli9 Dec 2024 9:15 AM ISTSeborrheic dermatitis is a prevalent inflammatory skin condition characterized by papulosquamous lesions, primarily affecting areas abundant in...
Cutaneous systemic lupus associated with increased risk for ASCVD, reveals research Written By Dr Riya Dave8 Dec 2024 10:30 PM ISTResearchers have established that an association exists between cutaneous lupus erythematosus (CLE) and an increased risk for atherosclerotic...
Microneedle Betamethasone delivery efficacious, less painful for managing mild-to-moderate alopecia areata: Study Written By Dr Riya Dave6 Dec 2024 8:15 PM ISTResearchers have found that microneedle transdermal delivery of compound betamethasone is just as effective as traditional intralesional injections...
Deucravacitinib Found to Be Safe and Effective for Psoriasis Over 3 Years: JAMA Written By Dr Riya Dave5 Dec 2024 8:15 PM ISTResearchers have found that deucravacitinib for long-term treatment is well tolerated and has a sustained clinical response in the management of...
Early-Onset Atopic Dermatitis Linked to Increased Risk of Atopic March: Study Identifies Key Risk Factors Written By Medha Baranwal4 Dec 2024 8:00 PM ISTUSA: A recent study has found that early-onset atopic dermatitis (AD), diagnosed before the age of one, is linked to a heightened risk of asthma...
Rare Case of Dermal Filler-Induced Hair Loss, Highlights Importance of Early Intervention Written By Medha Baranwal3 Dec 2024 11:00 PM ISTSaudi Arabia: A recent case report and literature review published in the Journal of Cosmetic Dermatology highlight a rare but concerning complication...
JnJ seeks USFDA nod for Tremfya for treatment of plaque psoriasis, juvenile psoriatic arthritis in children Written By Ruchika Sharma3 Dec 2024 12:30 PM ISTSpring House: Johnson & Johnson has announced the submission of two supplemental Biologics License Applications (sBLAs) to the U.S. Food and...
Ultraprocessed Foods Linked to Active Psoriasis Risk, finds study Written By Dr Riya Dave2 Dec 2024 8:00 PM ISTRecent findings from a new study have revealed that heavy ultraprocessed foods intakes, such as that by sodas and frozen pizzas, have been correlated...
